cas 504438-22-6|| where to buy (R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one

Nombre del producto:(R)-3-(3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-5-(hydroxymethyl)oxazolidin-2-one

IUPAC Name:(5R)-3-[3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-5-(hydroxymethyl)-1,3-oxazolidin-2-one

Unidad de embalaje	Stock disponible	Precio($)	Cantidad
CM134310-1g	in stock	ŴȁŴȷ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 504438-22-6 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :504438-22-6; Fórmula molecular:C16H21BFNO5; Punto de fusión:-; Código de sonrisas:O=C1O[C@@H](CO)CN1C2=CC=C(B3OC(C)(C)C(C)(C)O3)C(F)=C2; Densidad:

: Número de catálogo:CM134310; Peso molecular:337.15; Punto de ebullición:; Nº Mdl:MFCD22200821; Almacenamiento:

: Oxazolidines; Oxazolidines are five-membered ring compounds consisting of three carbons, nitrogen and oxygen. Oxygen and nitrogen are in the 1 and 3 positions, respectively. Oxazolidine is in general yellow or slightly yellow, alkaline liquid or solid, easily hydrolyzed by water or alcohol. It is insoluble in water (or hydrolyzed); soluble in benzene and chloroform. Oxazolidine derivatives are five-membered cyclic compounds containing at least one oxygen and nitrogen in their molecular structure. Oxazolidine derivatives are known to possess various therapeutic activities, such as anticancer and antibiotic properties.

: Boronic Acids and Esters; Boronic acids and boronate esters are commonly used reagents in Suzuki–Miyaura coupling chemistry. Organoboron derivatives are common reagents for C–C bond formation, either through classical palladium-mediated transformations or through other newer coupling methods. Boronic esters and acids are potential intermediates in the manufacture of many active pharmaceutical ingredients (API).